Inflammation & Allergy - Drug Targets (Discontinued)
Title: Editorial from Editor-in-Chief
Volume: 9 Issue: 1
Author(s): Kurt S. Zaenker
Affiliation:
Export Options
About this article
Cite this article as:
Zaenker S. Kurt, Editorial from Editor-in-Chief, Inflammation & Allergy - Drug Targets (Discontinued) 2010; 9 (1) . https://dx.doi.org/10.2174/187152810791292917
DOI https://dx.doi.org/10.2174/187152810791292917 |
Print ISSN 1871-5281 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4055 |
Article Metrics
Related Articles
-
TNF-α and Ghrelin: Opposite Effects on Immune System, Metabolism and Mental Health
Protein & Peptide Letters High-Density Lipoprotein at the Interface of Type 2 Diabetes Mellitus And Cardiovascular Disorders
Current Pharmaceutical Design Telocytes in Liver
Current Stem Cell Research & Therapy Comparative Study and Classification of Human Chemokine Receptors
Current Proteomics Patent Selections
Recent Patents on Anti-Infective Drug Discovery Plasmacytoid Dendritic Cells Count in Antiretroviral-Treated Patients is Predictive of HIV Load Control Independent of CD4+ T-Cell Count
Current HIV Research Omega-3 Polyunsaturated Fatty Acids and Depression: A Review of the Evidence
Current Pharmaceutical Design PEDF as an Emerging Therapeutic Candidate for Osteosarcoma
Current Cancer Drug Targets Role of Whole Plant Extract of Nelumbo nucifera Gaertn in the Treatment of Thrombolysis
Cardiovascular & Hematological Agents in Medicinal Chemistry Central Actions of Somatostatin-28 and Oligosomatostatin Agonists to Prevent Components of the Endocrine, Autonomic and Visceral Responses to Stress Through Interaction with Different Somatostatin Receptor Subtypes
Current Pharmaceutical Design Gene Therapy and Photothermal Therapy of Layer-by-Layer Assembled AuNCs /PEI/miRNA/ HA Nanocomplexes
Current Cancer Drug Targets Control of Autoimmune Diseases by the B7-CD28 Family Molecules
Current Pharmaceutical Design B Cells: Programmers of CD4 T Cell Responses
Infectious Disorders - Drug Targets Sleep-Inducing Factors
CNS & Neurological Disorders - Drug Targets Eicosanoids in Asthma, Allergic Inflammation, and Host Defense
Current Molecular Medicine Chondroitin Sulfate and Glucosamine as Disease Modifying Anti- Osteoarthritis Dru gs (DMOADs)
Current Medicinal Chemistry Antimicrobial Proteins from Snake Venoms: Direct Bacterial Damage and Activation of Innate Immunity Against Staphylococcus aureus Skin Infection
Current Medicinal Chemistry Down Regulation of Differentiated Embryo-Chondrocyte Expressed Gene 1 is Related to the Decrease of Osteogenic Capacity
Current Drug Targets The Novel Functions of cGMP-Specific Phosphodiesterase 5 and its Inhibitors in Carcinoma Cells and Pulmonary/Cardiovascular Vessels
Current Topics in Medicinal Chemistry Chelating Agents for Neurodegenerative Diseases
Current Medicinal Chemistry